Kent Pharma Earns EcoVadis Gold Rating for the 2nd Year running

This recognition reflects Kent Pharma's continued commitment to Environmental, Social, and Governance (ESG) principles, reinforcing its significant role in the pharmaceutical industry.

EcoVadis is a globally trusted platform that assesses and rates the business sustainability performance of companies. With over 150,000 rated organisations, EcoVadis provides a detailed overview of a company’s sustainability practices across various industries.

Kent Pharma was evaluated under four main themes: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. The Gold rating places Kent Pharma among the top 5% of companies assessed by EcoVadis, demonstrating consistent improvements in its sustainability efforts.

Key strengths from this year’s assessment include:

• Comprehensive environmental policies covering customer health & safety, energy usage & greenhouse gas emissions, materials, chemicals, and waste management.
• Clear, measurable objectives for energy consumption and greenhouse gas emissions.
• An advanced management system for addressing ethical issues.

Kent-Athlone Pharma Group’s CEO, Terry Petersen, expressed pride in the recognition, stating, “Many congratulations to the whole Kent-Athlone Pharma Group Team, for their efforts and achieving another key milestone in our Corporate Social Responsibility journey as a company”.

This achievement further solidifies Kent-Athlone Pharma Group’s dedication to integrating sustainability into its operations, ensuring responsible growth and continued leadership in the pharmaceutical sector.